Gene expression profiling of papillary thyroid carcinomas in Korean patients by oligonucleotide microarrays

Journal of the Korean Surgical Society

Volumn 82, Issue 5, 2012, Pages 271-280

  Chung, Ki Wook ^a   Kim, Sun Wook ^b   Kim, Seok Won ^a  

^a National Cancer Center   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Gene expression profiling; Microarray; Papillary; Thyroidneoplasms

Indexed keywords

EID: 84861606033     PISSN: 12260053     EISSN: 20930488     Source Type: Journal    
DOI: 10.4174/jkss.2012.82.5.271     Document Type: Article

References (30)

1. Ministry of Health & Welfare; National Cancer Center. Cancer facts and figures 2011 in the Republic Korea. Goyang: National Cancer Center; 2011.
2. Yu GP, Li JC, Branovan D, McCormick S, Schantz SP. Thyroid cancer incidence and survival in the national cancer institute surveillance, epidemiology, and end results race/ethnicity groups. Thyroid 2010;20:465-73.
3. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 2006;295:2164-7.
4. Nishiyama RH. Pathology of tumors of the thyroid gland. In: Clark OH, Duh QY, Kebebew E, editors. Textbook of endocrine surgery. 2nd ed. Philadelphia: Elsevire Saunders; 2005. p.223-47.
5. Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, et al. A multigene assay to predict recurrence of tamoxifen- treated, node-negative breast cancer. N Engl J Med 2004;351: 2817-26. (Pubitemid 40051905)
6. Reiner A, Yekutieli D, Benjamini Y. Identifying differentially expressed genes using false discovery rate controlling procedures. Bioinformatics 2003;19:368-75. (Pubitemid 36284936)
7. Wasenius VM, Hemmer S, Kettunen E, Knuutila S, Franssila K, Joensuu H. Hepatocyte growth factor receptor, matrix metalloproteinase-11, tissue inhibitor of metalloproteinase-1, and fibronectin are up-regulated in papillary thyroid carcinoma: a cDNA and tissue microarray study. Clin Cancer Res 2003;9:68-75. (Pubitemid 36109717)
8. Huang Y, Prasad M, Lemon WJ, Hampel H, Wright FA, Kornacker K, et al. Gene expression in papillary thyroid carcinoma reveals highly consistent profiles. Proc Natl Acad Sci U S A 2001;98:15044-9. (Pubitemid 34013966)
9. Aldred MA, Huang Y, Liyanarachchi S, Pellegata NS, Gimm O, Jhiang S, et al. Papillary and follicular thyroid carcinomas show distinctly different microarray expression profiles and can be distinguished by a minimum of five genes. J Clin Oncol 2004;22:3531-9. (Pubitemid 41103659)
10. Carpi A, Mechanick JI, Saussez S, Nicolini A. Thyroid tumor marker genomics and proteomics: diagnostic and clinical implications. J Cell Physiol 2010;224:612-9.
11. Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, et al. Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc Natl Acad Sci U S A 2004;101:9309-14. (Pubitemid 38812872)
12. Griffith OL, Melck A, Jones SJ, Wiseman SM. Meta-analysis and meta-review of thyroid cancer gene expression profiling studies identifies important diagnostic biomarkers. J Clin Oncol 2006;24:5043-51. (Pubitemid 46631408)
13. Kim HS, Kim DH, Kim JY, Jeoung NH, Lee IK, Bong JG, et al. Microarray analysis of papillary thyroid cancers in Korean. Korean J Intern Med 2010;25:399-407.
14. Giordano S, Di Renzo MF, Narsimhan RP, Cooper CS, Rosa C, Comoglio PM. Biosynthesis of the protein encoded by the c-met proto-oncogene. Oncogene 1989;4:1383-8. (Pubitemid 19273394)
15. Mineo R, Costantino A, Frasca F, Sciacca L, Russo S, Vigneri R, et al. Activation of the hepatocyte growth factor (HGF)-Met system in papillary thyroid cancer: biological effects of HGF in thyroid cancer cells depend on Met expression levels. Endocrinology 2004;145:4355-65. (Pubitemid 39120585)
16. Benjamini Y, Lipkind D, Horev G, Fonio E, Kafkafi N, Golani I. Ten ways to improve the quality of descriptions of whole-animal movement. Neurosci Biobehav Rev 2010;34: 1351-65.
17. Bergstrom JD, Westermark B, Heldin NE. Epidermal growth factor receptor signaling activates met in human anaplastic thyroid carcinoma cells. Exp Cell Res 2000;259: 293-9.
18. Benjamini Y, Yekutieli D. Quantitative trait Loci analysis using the false discovery rate. Genetics 2005;171:783-90. (Pubitemid 43156463)
19. Thomassen M, Tan Q, Kruse TA. Gene expression meta-analysis identifies chromosomal regions and candidate genes involved in breast cancer metastasis. Breast Cancer Res Treat 2009;113:239-49.
20. Carvallo L, Munoz R, Bustos F, Escobedo N, Carrasco H, Olivares G, et al. Non-canonical Wnt signaling induces ubiquitination and degradation of Syndecan4. J Biol Chem 2010;285:29546-55.
21. Bashyam MD, Bair R, Kim YH, Wang P, Hernandez-Boussard T, Karikari CA, et al. Array-based comparative genomic hybridization identifies localized DNA amplifications and homozygous deletions in pancreatic cancer. Neoplasia 2005;7:556-62. (Pubitemid 40967756)
22. Gorres KL, Raines RT. Prolyl 4-hydroxylase. Crit Rev Biochem Mol Biol 2010;45:106-24.
23. Teodoro JG, Parker AE, Zhu X, Green MR. p53-mediated inhibition of angiogenesis through up-regulation of a collagen prolyl hydroxylase. Science 2006;313:968-71. (Pubitemid 44267388)
24. Conacci-Sorrell M, Zhurinsky J, Ben-Ze'ev A. The cadherin-catenin adhesion system in signaling and cancer. J Clin Invest 2002;109:987-91. (Pubitemid 34408571)
25. Turashvili G, McKinney SE, Goktepe O, Leung SC, Huntsman DG, Gelmon KA, et al. P-cadherin expression as a prognostic biomarker in a 3992 case tissue microarray series of breast cancer. Mod Pathol 2011;24:64-81.
26. Zhang CC, Yan Z, Zhang Q, Kuszpit K, Zasadny K, Qiu M, et al. PF-03732010: a fully human monoclonal antibody against P-cadherin with antitumor and antimetastatic activity. Clin Cancer Res 2010;16:5177-88.
27. Rodrigues NR, Theodosiou AM, Nesbit MA, Campbell L, Tandle AT, Saranath D, et al. Characterization of Ngef, a novel member of the Dbl family of genes expressed predominantly in the caudate nucleus. Genomics 2000;65: 53-61. (Pubitemid 30249915)
28. Yukinawa N, Oba S, Kato K, Taniguchi K, Iwao-Koizumi K, Tamaki Y, et al. A multi-class predictor based on a probabilistic model: application to gene expression profiling-based diagnosis of thyroid tumors. BMC Genomics 2006;7:190.
29. Krause K, Eszlinger M, Gimm O, Karger S, Engelhardt C, Dralle H, et al. TFF3-based candidate gene discrimination of benign and malignant thyroid tumors in a region with borderline iodine deficiency. J Clin Endocrinol Metab 2008;93:1390-3. (Pubitemid 351519738)
30. Nikolova DN, Zembutsu H, Sechanov T, Vidinov K, Kee LS, Ivanova R, et al. Genome-wide gene expression profiles of thyroid carcinoma: identification of molecular targets for treatment of thyroid carcinoma. Oncol Rep 2008;20: 105-21.